Specific fluorescence assay for advanced glycation end products in blood and urine of diabetic patients
- 1 November 1998
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 47 (11) , 1348-1353
- https://doi.org/10.1016/s0026-0495(98)90303-1
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Advanced glycation endproducts — associated parameters in the peripheral blood of patients with Alzheimer's diseaseLife Sciences, 1996
- Modification of β2m with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serumKidney International, 1996
- Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPDKidney International, 1994
- Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failureThe Lancet, 1994
- Hemoglobin-AGE: A Circulating Marker of Advanced GlycosylationScience, 1992
- Non-tryptophan fluorescence and high molecular weight protein formation in lens crystallins of rats with chronic galactosemia: Prevention by the aldose reductase inhibitor sorbinilExperimental Eye Research, 1990
- End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen.Journal of Clinical Investigation, 1990
- Production and characterization of antibodies to advanced glycation products on proteinsBiochemical and Biophysical Research Communications, 1989
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988
- Relation between Complications of Type I Diabetes Mellitus and Collagen-Linked FluorescenceNew England Journal of Medicine, 1986